Human Genome Epidemiology Literature Finder
Records 1 - 13 (of 13 Records) |
Query Trace: Lung Neoplasms and AR[original query] |
---|
Polymorphic metabolizing genes and susceptibility to atherosclerosis among cigarette smokers. Environmental and molecular mutagenesis 2002 40 (3): 153-60. Salama Salama A, Au William W, Hunter Glenn C, Sheahan Richard G, Badary Osama A, Abdel-Naim Ashraf B, Hamada Farid M |
Androgen receptor CAG repeats, non-random X chromosome inactivation, and loss of heterozygosity at Xq25 in relation to breast cancer risk. BMC cancer 2014 14 144. Chen Hui-Tzu, Wu Yao-Chung, Chen Shou-Tung, Tsai Hsien-Chang, Chien Yi-Ch |
The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer. Oncotarget 2016 May . Gou Lan-Ying, Li An-Na, Yang Jin-Ji, Zhang Xu-Chao, Su Jian, Yan Hong-Hong, Xie Zhi, Lou Na-Na, Liu Si-Yang, Dong Zhong-Yi, Gao Hong-Fei, Zhou Qing, Zhong Wen-Zhao, Xu Chong-Rui, Wu Yi-Lo |
A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR-Tyrosine Kinase Inhibitors. Cancer research and treatment : official journal of Korean Cancer Association 2016 May . Han Ji-Youn, Lee Ki Hyeong, Kim Sang-We, Min Young Joo, Cho Eunkyung, Lee Youngjoo, Lee Soo-Hyun, Kim Hyae Young, Lee Geon Kook, Nam Byung Ho, Han Hyesun, Jung Jina, Lee Jin S |
Radon Exposure-induced Genetic Variations in Lung Cancers among Never Smokers. Journal of Korean medical science 2018 7 33 (29): e207. Choi Jung Ran, Koh Sang Baek, Kim Hye Ryun, Lee Hyojin, Kang Dae Ryo |
Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer. JCO precision oncology 2020 9 3 . Michels Sebastian, Heydt Carina, van Veggel Bianca, Deschler-Baier Barbara, Pardo Nuria, Monkhorst Kim, Rüsseler Vanessa, Stratmann Jan, Griesinger Frank, Steinhauser Susanne, Kostenko Anna, Diebold Joachim, Fassunke Jana, Fischer Rieke, Engel-Riedel Walburga, Gautschi Oliver, Geissinger Eva, Haneder Stefan, Ihle Michaela A, Kopp Hans-Georg, de Langen Adrianus J, Martinez-Marti Alex, Nogova Lucia, Persigehl Thorsten, Plenker Dennis, Puesken Michael, Rodermann Ernst, Rosenwald Andreas, Scheel Andreas H, Scheffler Matthias, Spengler Werner, Seggewiss-Bernhardt Ruth, Brägelmann Johannes, Sebastian Martin, Vrugt Bart, Hellmich Martin, Sos Martin L, Heukamp Lukas C, Felip Enriqueta, Merkelbach-Bruse Sabine, Smit Egbert F, Büttner Reinhard, Wolf Jürg |
Genomic and evolutionary classification of lung cancer in never smokers. Nature genetics 2021 9 53 (9): 1348-1359. Zhang Tongwu, Joubert Philippe, Ansari-Pour Naser, Zhao Wei, Hoang Phuc H, Lokanga Rachel, Moye Aaron L, Rosenbaum Jennifer, Gonzalez-Perez Abel, Martínez-Jiménez Francisco, Castro Andrea, Muscarella Lucia Anna, Hofman Paul, Consonni Dario, Pesatori Angela C, Kebede Michael, Li Mengying, Gould Rothberg Bonnie E, Peneva Iliana, Schabath Matthew B, Poeta Maria Luana, Costantini Manuela, Hirsch Daniela, Heselmeyer-Haddad Kerstin, Hutchinson Amy, Olanich Mary, Lawrence Scott M, Lenz Petra, Duggan Maire, Bhawsar Praphulla M S, Sang Jian, Kim Jung, Mendoza Laura, Saini Natalie, Klimczak Leszek J, Islam S M Ashiqul, Otlu Burcak, Khandekar Azhar, Cole Nathan, Stewart Douglas R, Choi Jiyeon, Brown Kevin M, Caporaso Neil E, Wilson Samuel H, Pommier Yves, Lan Qing, Rothman Nathaniel, Almeida Jonas S, Carter Hannah, Ried Thomas, Kim Carla F, Lopez-Bigas Nuria, Garcia-Closas Montserrat, Shi Jianxin, Bossé Yohan, Zhu Bin, Gordenin Dmitry A, Alexandrov Ludmil B, Chanock Stephen J, Wedge David C, Landi Maria Tere |
Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing. Journal of thoracic disease 2021 Aug 13 (8): 5007-5015. Zhang Fan, Wang Junyan, Ma Minting, Xu Yu, Lu Xiangjun, Wei Su |
Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy. Translational lung cancer research 2020 Dec 9 (6): 2367-2379. Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y |
RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer. Journal of translational medicine 2022 Sep 20 (1): 390. Wang Chunyue, Zhang Zhenlong, Sun Yulan, Wang Song, Wu Mengmeng, Ou Qiuxiang, Xu Yang, Chen Zhiming, Shao Yang, Liu Hong, Hou Peife |
Genomic features of Chinese small cell lung cancer. BMC medical genomics 2022 May 15 (1): 117. Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw |
Novel mutation signatures in the prognosis of EGFR-TKIs targeted therapy for non-small cell lung cancer patients based on the 1000-gene panel sequencing. Neoplasma 2022 Jan . Zhang Hui, Jiang Da, Jin Hui, Cui Yan-Zhi, Wei Su-Ju, Li Ying, Dong Qian, Zuo Jing, Tian Cai-Juan, Yan Fang, Wang Xiao-W |
Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 7 182 107292. Georgios Tsakonas, Vasisht Tadigotla, Sudipto K Chakrabortty, Giuseppe Stragliotto, Dalin Chan, Rolf Lewensohn, Wei Yu, Johan K Skog, Per Hydbring, Simon Ekm |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: